
# 强迫性补量

[◀返回](./home.md)

**强迫性补量**被定义为一种强烈且难以抵抗的冲动，想要不断地追加服用[精神活性物质](/药物/home.md)，试图增加或维持其引发的[主观效应](/文档/药效/home.md)呢。[1][2][3][4]

当使用者手头有大量这种物质时，这种效应会明显更容易出现哦。可以通过预先称量好[剂量](/文档/给药剂量.md)、不要把剩下的东西放在眼皮子底下、发挥自我控制力，或者把东西交给信任的人保管直到他们认为安全归还为止，来部分避免这种情况嘛。

强迫性补量通常伴随着其他并发效应，比如[认知欣快](/药效/认知欣快.md)、[躯体欣快](/药效/躯体欣快.md)或[焦虑抑制](/药效/焦虑.md)，以及其他会抑制判断清晰度的效应，例如[去抑制](/药效/去抑制.md)、[动机增强](/药效/动机增强.md)和[自我膨胀](/药效/自我膨胀.md)。这种现象最常在[中等](/文档/药物剂量分类.md#中等)[剂量](/文档/给药剂量.md)的各类化合物影响下被诱发，比如[阿片类药物](/文档/药物分类/阿片类药物.md)、[兴奋剂](/文档/药物分类/兴奋剂.md)、[2][4][5] [GABA类](/文档/GABA.md)物质[2]以及[共情剂](/文档/药物分类/共情剂.md)呢。[3] 不过，在[解离剂](/文档/药物分类/解离剂.md)和[大麻类](/文档/药物分类/大麻类.md)物质的影响下，也可能出现程度较轻的这种情况哦。[3]

<!-- 请勿删除或修改，这是一个标记，待识别并填坑（药效索引） -->

### 体验报告

在我们的[体验索引](/文档/home.md)中，描述此效应的轶事报告包括：

* [Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us](/报告/psychounautwiki/Experience:_36mg_4-AcO-DiPT_-_Truly,_one_for_the_psychedelic_animals_among_us)
* [Experience:1.2 g gabapentin, alcohol, and half of 150 mg Effexor XR - Pretty lovely for socializing and giggles](/报告/psychounautwiki/Experience:1.2_g_gabapentin,_alcohol,_and_half_of_150_mg_Effexor_XR_-_Pretty_lovely_for_socializing_and_giggles)
* [Experience:100/100/100mg, first time with it](/报告/psychounautwiki/Experience:100/100/100mg,_first_time_with_it)
* [Experience:110mg Diphenidine (vaporized) + 354mg DXM - instant ego death](/报告/psychounautwiki/Experience:110mg_Diphenidine_(vaporized)_%2B_354mg_DXM_-_instant_ego_death)
* [Experience:1g Methiopropamine - Chasing the Chalky Dragon](/报告/psychounautwiki/Experience:1g_Methiopropamine_-_Chasing_the_Chalky_Dragon)
* [Experience:20mg Etizolam - Smoking Etizolam](/报告/psychounautwiki/Experience:20mg_Etizolam_-_Smoking_Etizolam)
* [Experience:20mg Heroin - The Last Time I Shot Up](/报告/psychounautwiki/Experience:20mg_Heroin_-_The_Last_Time_I_Shot_Up)
* [Experience:25mg 3-MeO-PCP - Enhanced film experience](/报告/psychounautwiki/Experience:25mg_3-MeO-PCP_-_Enhanced_film_experience)
* [Experience:25mg Deschloroketamine - My first time orally dosing DCK](/报告/psychounautwiki/Experience:25mg_Deschloroketamine_-_My_first_time_orally_dosing_DCK)
* [Experience:260 mg Ketamine (insufflated) - Lost in Paisley](/报告/psychounautwiki/Experience:260_mg_Ketamine_(insufflated)_-_Lost_in_Paisley)
* [Experience:2mg Etizolam & N2O - "Hippy Crack" Indeed](/报告/psychounautwiki/Experience:2mg_Etizolam_%26_N2O_-_%22Hippy_Crack%22_Indeed)
* [Experience:2mg Etizolam - Here be dragons](/报告/psychounautwiki/Experience:2mg_Etizolam_-_Here_be_dragons)
* [Experience:3-MeO-PCP - Extreme psychosis](/报告/psychounautwiki/Experience:3-MeO-PCP_-_Extreme_psychosis)
* [Experience:3-MeO-PCP, LSD, Clonazolam, and Amphetamine - Excessive Amounts and Excessive Confusion](/报告/psychounautwiki/Experience:3-MeO-PCP,_LSD,_Clonazolam,_and_Amphetamine_-_Excessive_Amounts_and_Excessive_Confusion)
* [Experience:30mg Isopropylphenidate - IPPH As A Study Aid](/报告/psychounautwiki/Experience:30mg_Isopropylphenidate_-_IPPH_As_A_Study_Aid)
* [Experience:37mg Isopropylphenidate - Getting Shit Done With Isopropylphenidate](/报告/psychounautwiki/Experience:37mg_Isopropylphenidate_-_Getting_Shit_Done_With_Isopropylphenidate)
* [Experience:3mg Etizolam - A Comedown Drug](/报告/psychounautwiki/Experience:3mg_Etizolam_-_A_Comedown_Drug)
* [Experience:60mg Zolpidem - A Delirious Adventure](/报告/psychounautwiki/Experience:60mg_Zolpidem_-_A_Delirious_Adventure)
* [Experience:A night with Ethylphenidate](/报告/psychounautwiki/Experience:A_night_with_Ethylphenidate)
* [Experience:Alprazolam (24 mg) - Into the Void](/报告/psychounautwiki/Experience:Alprazolam_(24_mg)_-_Into_the_Void)
* [Experience:Datura and nicotine smoked - 4 and ~15 hits; was actually quite pleasant](/报告/psychounautwiki/Experience:Datura_and_nicotine_smoked_-_4_and_~15_hits;_was_actually_quite_pleasant)
* [Experience:FMA (37.5 mg, oral) - Never been this productive in my life](/报告/psychounautwiki/Experience:FMA_(37.5_mg,_oral)_-_Never_been_this_productive_in_my_life)
* [Experience:Nitrous oxide (approx. 50 puffs) - ~50 puffs nitrous oxide](/报告/psychounautwiki/Experience:Nitrous_oxide_(approx._50_puffs)_-_~50_puffs_nitrous_oxide)

### 另见

* [负责任的用药](/文档/负责任的用药索引页.md)
* [主观效应索引](/文档/药效/home.md)
* [迷幻剂 - 主观效应](/文档/药物分类/迷幻剂.md#主观效应)
* [解离剂 - 主观效应](/文档/药物分类/解离剂.md#主观效应)
* [谵妄剂 - 主观效应](/文档/药物分类/谵妄剂.md#主观效应)
* [N-乙酰半胱氨酸](/文档/N-乙酰半胱氨酸.md)

### 外部链接

* [Psychological dependence (Wikipedia)](https://en.wikipedia.org/wiki/Psychological_dependence)

### References

1. [↑](#cite_ref-EverittRobbins2005_1-0) Everitt, Barry J; Robbins, Trevor W (2005). "Neural systems of reinforcement for drug addiction: from actions to habits to compulsion". *Nature Neuroscience*. **8** (11): 1481–1489. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1038/nn1579](//doi.org/10.1038%2Fnn1579). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1097-6256](//www.worldcat.org/issn/1097-6256). 
2. ↑ [2.0](#cite_ref-Volkow2000_2-0) [2.1](#cite_ref-Volkow2000_2-1) [2.2](#cite_ref-Volkow2000_2-2) Volkow, N. D. (2000). "Addiction, a Disease of Compulsion and Drive: Involvement of the Orbitofrontal Cortex". *Cerebral Cortex*. **10** (3): 318–325. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1093/cercor/10.3.318](//doi.org/10.1093%2Fcercor%2F10.3.318). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1460-2199](//www.worldcat.org/issn/1460-2199). 
3. ↑ [3.0](#cite_ref-HymanMalenka2001_3-0) [3.1](#cite_ref-HymanMalenka2001_3-1) [3.2](#cite_ref-HymanMalenka2001_3-2) Hyman, Steven E.; Malenka, Robert C. (2001). "Addiction and the brain: The neurobiology of compulsion and its persistence". *Nature Reviews Neuroscience*. **2** (10): 695–703. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1038/35094560](//doi.org/10.1038%2F35094560). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1471-003X](//www.worldcat.org/issn/1471-003X). 
4. ↑ [4.0](#cite_ref-SoussanKjellgren2015_4-0) [4.1](#cite_ref-SoussanKjellgren2015_4-1) Soussan, Christophe; Kjellgren, Anette (2015). ""Chasing the High" – Experiences of Ethylphenidate as Described on International Internet Forums". *Substance Abuse: Research and Treatment*. **9**: SART.S22495. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.4137/SART.S22495](//doi.org/10.4137%2FSART.S22495). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1178-2218](//www.worldcat.org/issn/1178-2218). 
5. [↑](#cite_ref-OlivesOrozco2012_5-0) Olives, Travis; Orozco, Benjamin; Stellpflug, Samuel (2012). "Bath Salts: The Ivory Wave of Trouble". *Western Journal of Emergency Medicine*. **13** (1): 58–62. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.5811/westjem.2011.6.6782](//doi.org/10.5811%2Fwestjem.2011.6.6782). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1936-900X](//www.worldcat.org/issn/1936-900X). 
6. [↑](#cite_ref-6) Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, et al. (March 2014). ["Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3473160). *Addiction Biology*. **19** (2): 165–74. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1111/j.1369-1600.2012.00474.x](//doi.org/10.1111%2Fj.1369-1600.2012.00474.x). [PMC](http://en.wikipedia.org/wiki/PubMed_Central "wikipedia:PubMed Central") [3473160](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3473160) ![Freely accessible](https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/langen-gb-20px-Lock-green.svg.png "Freely accessible"). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [22784198](//www.ncbi.nlm.nih.gov/pubmed/22784198). 
7. [↑](#cite_ref-7) Coppola M, Mondola R (January 2012). "3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online". *Toxicology Letters*. **208** (1): 12–5. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.toxlet.2011.10.002](//doi.org/10.1016%2Fj.toxlet.2011.10.002). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [22008731](//www.ncbi.nlm.nih.gov/pubmed/22008731).